Health Care Up as Health Insurer Rebound Continues - Health Care Roundup
Health-care companies rose as traders rotated into sectors with less to lose from rising inflation.
Shares of health insurers such as UnitedHealth, Humana and Cigna added to recent gains amid renewed optimism about the earnings growth outlook for the sub sector.
The European Union's antitrust body said it accepted Sanofi's concessions to settle a competition investigation into the French drugmaker's marketing campaign for a flu vaccine.
One of Malaysia's largest pharmacy chains, Big Caring, is planning an initial public offering to raise up to $600 million, testing investor appetite in a highly volatile market.
Swiss contract drug maker Lonza Group reiterated its full-year growth outlook and vowed to focus on cost disciplines. Another Swiss firm, dermatology-drug maker Galderma, agreed to buy ZO Skin Health from investment firm Blackstone, the Obagi family and other shareholders for $1.5 billion, including debt.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
October 14, 2026 16:54 ET (20:54 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
Are TIPS ETFs the Best Way to Fight Inflation?
What’s Ahead for Stocks This Quarter—and Where to Invest
10 Best Blue-Chip Stocks to Buy for the Long Term
United States